FIA
FOLD

FNY Investment Advisers’s Amicus Therapeutics FOLD Stock Holding History

FNY Investment Advisers’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$1K – 788
2018
Q3 		$1K Buy
+100
New +$1.4K ﹤0.01% 782

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's FOLD Position: Q2 2026 in Review

FNY Investment Advisers sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 278,670 shares — an estimated $4.03M sold.

FNY Investment Advisers first reported a position in FOLD in Q2 2018 and held it in 5 quarters. The position peaked at $4.03M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • FNY Investment Advisers reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 278,670 Amicus Therapeutics shares in Q2 2026, an estimated $4.03M.
  • FNY Investment Advisers first reported a position in Amicus Therapeutics in Q2 2018 and held it in 5 quarters.
  • FNY Investment Advisers's Amicus Therapeutics position peaked at $4.03M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.